InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: Echo20 post# 225977

Wednesday, 04/25/2018 1:35:39 AM

Wednesday, April 25, 2018 1:35:39 AM

Post# of 403018
Echo20,

"P could work wonders without all of the toxicity and troubles."

Could is right,don't know if it will work wonders, but I do think P along with some other medicines will exceed the "benefits" of Otezla.

Not sure if you saw this(my) post from a little while ago, but Valeant has 3 products in stage 3 psoriasis trials(not listed in the link below as I was trying to compare apples to apples(completed phase 2 psoriasis trials). You'll find my post below(listed in order from clinicaltrials, I rerragained the listed order from the site, based on figures given, to patients enrolled per day(I suspect patients and doctors want what is best).

IPIX ranks #3 of 14 by my matrix. #2 on the trial list(Kayowa) concluded 5 years ago. # 1((valeant) is a monster, but compare the outcome measures(they've bought out a few cos. for the psoriasis indication).

If Leo ain't lyin, as some suggest, we are golden(just on P). Time shall tell

Here's my post referenced above:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140289370


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News